Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001628280-26-020236 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 20, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
45,000
Total Value
$339,212.69
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 18, 2026 | Exercise/Conversion | 6,499 | $3.79 | $24,629.91 | 345,891 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 18, 2026 | Sale | 6,499 | $18.84 | $122,414.51 | 339,392 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 19, 2026 | Exercise/Conversion | 6,905 | $3.79 | $26,168.57 | 346,297 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 19, 2026 | Sale | 6,905 | $18.78 | $129,704.90 | 339,392 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 20, 2026 | Exercise/Conversion | 1,596 | $3.79 | $6,048.52 | 340,988 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 20, 2026 | Sale | 1,596 | $18.95 | $30,246.27 | 339,392 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 18, 2026 | Exercise/Conversion | 6,499 | $0.00 | $0.00 | 184,608 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 19, 2026 | Exercise/Conversion | 6,905 | $0.00 | $0.00 | 177,703 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 20, 2026 | Exercise/Conversion | 1,596 | $0.00 | $0.00 | 176,107 | Direct | โ | View Details |